Tuesday, November 24, 2020

Why AstraZeneca-Oxford potential COVID vaccine works better in low dose

Why AstraZeneca-Oxford potential COVID vaccine works better in low dose They have claimed that the drug is 70.4 percent effective, and it makes a strong case for AstraZeneca#39;s India partner Serum Institute of India to seek licence for its potential vaccine, Covishield, in India.

from Moneycontrol Business News https://ift.tt/3nUdVHo
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

European shares log weekly losses on Iran war-linked inflation woesdrop

European markets experienced a significant downturn, with the STOXX 600 index sliding due to escalating energy inflation fears stemming from...